M Findlay
Impact in
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
-
- Gastric Cancer Management and Outcomes
- Metastasis and carcinoma case studies
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 5
- Colorectal Cancer Treatments and Studies 5
- Cancer Treatment and Pharmacology 2
- Cancer Diagnosis and Treatment 1
-
- Genetic factors in colorectal cancer 2
- Co-authors
- David Cunningham (4 shared papers)A. Norman (2 shared papers)Andrew Webb (2 shared papers)Tamas Hickish (2 shared papers)Andrew Wardley (1 shared paper)Andrew Hill (1 shared paper)Craig Underhill (1 shared paper)Janine Mansi (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)European Journal of Cancer (1 paper)Breast Cancer Research and Treatment (1 paper)Human Mutation (1 paper)Value in Health (1 paper)
- Partner nations
- United KingdomItalyNew Zealand
In The Last Decade
M Findlay
8 papers receiving 883 citations
M Findlay's Hit Papers
Peers
Comparison fields: 5 of 52
- Gastroenterology 105
- Pulmonary and Respiratory Medicine 556
- Oncology 337
- Surgery 257
- Pathology and Forensic Medicine 50
Countries citing papers authored by M Findlay
This map shows the geographic impact of M Findlay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Findlay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Findlay more than expected).
Fields of papers citing papers by M Findlay
This network shows the impact of papers produced by M Findlay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Findlay. The network helps show where M Findlay may publish in the future.
Co-authors
The 25 scholars most cited alongside M Findlay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. Hit paper breakdown → | 1997 | 709 |
| 2 | 1995 | 73 | |
| 3 | 2002 | 58 | |
| 4 | 1996 | 51 | |
| 5 | 1997 | 14 | |
| 6 | Survival benefit with Xeloda (capecitabine)/docetaxel vs docetaxel: analysis of post-study therapy. | 2001 | 13 |
| 7 | 2000 | 1 | |
| 8 | 2008 | 1 | |
| 9 | 1993 | 0 |
About M Findlay
M Findlay is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Molecular Biology and Dermatology, having authored 9 papers that have together received 920 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), Genetic factors in colorectal cancer (2 papers), Cancer Treatment and Pharmacology (2 papers), Cancer Diagnosis and Treatment (1 paper), Radiomics and Machine Learning in Medical Imaging (1 paper), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Cancer Genomics and Diagnostics (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Gastroenterology (105 citations), Pulmonary and Respiratory Medicine (556 citations), Oncology (337 citations), Surgery (257 citations) and Pathology and Forensic Medicine (50 citations). M Findlay has collaborated with scholars based in United Kingdom, Italy and New Zealand. Frequent co-authors include David Cunningham, A. Norman, Andrew Webb, Tamas Hickish, Andrew Wardley, Andrew Hill, Craig Underhill, Janine Mansi, Peter Harper and M. A. HUGHES. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Breast Cancer Research and Treatment, Human Mutation and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.